Clinical Trial Update: Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluates the safety and efficacy of combining natalizumab with Avonex for relapsing-remitting multiple sclerosis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Avonex (Interferon beta-1a)
• Natalizumab (natalizumab)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Status: COMPLETED